Sign In
NASDAQ:AMTX
Aemetis Stock Earnings Reports
$1.68
+0.0900 (+5.66%)
At Close: Mar 14, 2025
Aemetis Earnings Calls
Q4 2024
Beat
-$0.355 (22.80%)
| Release date | Mar 13, 2025 |
| EPS estimate | -$0.460 |
| EPS actual | -$0.355 |
| EPS Surprise | 22.80% |
| Revenue estimate | 89.044M |
| Revenue actual | 47.004M |
| Revenue Surprise | -47.21% |
Q3 2024
Beat
-$0.380 (19.15%)
| Release date | Nov 12, 2024 |
| EPS estimate | -$0.470 |
| EPS actual | -$0.380 |
| EPS Surprise | 19.15% |
| Revenue estimate | 88.717M |
| Revenue actual | 81.441M |
| Revenue Surprise | -8.20% |
Q2 2024
Missed
-$0.660 (-13.79%)
| Release date | Aug 01, 2024 |
| EPS estimate | -$0.580 |
| EPS actual | -$0.660 |
| EPS Surprise | -13.79% |
| Revenue estimate | 80.78M |
| Revenue actual | 66.561M |
| Revenue Surprise | -17.60% |
Q1 2024
Missed
-$0.580 (-34.88%)
| Release date | May 09, 2024 |
| EPS estimate | -$0.430 |
| EPS actual | -$0.580 |
| EPS Surprise | -34.88% |
| Revenue estimate | 77.219M |
| Revenue actual | 72.634M |
| Revenue Surprise | -5.94% |
Last 4 Quarters for Aemetis
Below you can see how AMTX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q1 2024
Missed
| Release date | May 09, 2024 |
| Fiscal end date | Mar 31, 2024 |
| Price on release | $4.11 |
| EPS estimate | -$0.430 |
| EPS actual | -$0.580 |
| EPS surprise | -34.88% |
| Date | Price |
|---|---|
| May 03, 2024 | $4.11 |
| May 06, 2024 | $4.39 |
| May 07, 2024 | $4.05 |
| May 08, 2024 | $4.14 |
| May 09, 2024 | $4.11 |
| May 10, 2024 | $4.00 |
| May 13, 2024 | $4.01 |
| May 14, 2024 | $4.08 |
| May 15, 2024 | $4.15 |
| 4 days before | 0% |
| 4 days after | 0.97% |
| On release day | -2.68% |
| Change in period | 0.97% |
Q2 2024
Missed
| Release date | Aug 01, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $2.66 |
| EPS estimate | -$0.580 |
| EPS actual | -$0.660 |
| EPS surprise | -13.79% |
| Date | Price |
|---|---|
| Jul 26, 2024 | $3.59 |
| Jul 29, 2024 | $3.39 |
| Jul 30, 2024 | $3.42 |
| Jul 31, 2024 | $3.21 |
| Aug 01, 2024 | $2.66 |
| Aug 02, 2024 | $2.49 |
| Aug 05, 2024 | $2.53 |
| Aug 06, 2024 | $2.64 |
| Aug 07, 2024 | $2.52 |
| 4 days before | -25.91% |
| 4 days after | -5.26% |
| On release day | -6.39% |
| Change in period | -29.81% |
Q3 2024
Beat
| Release date | Nov 12, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $4.62 |
| EPS estimate | -$0.470 |
| EPS actual | -$0.380 |
| EPS surprise | 19.15% |
| Date | Price |
|---|---|
| Nov 06, 2024 | $2.80 |
| Nov 07, 2024 | $3.04 |
| Nov 08, 2024 | $3.35 |
| Nov 11, 2024 | $3.59 |
| Nov 12, 2024 | $4.62 |
| Nov 13, 2024 | $4.13 |
| Nov 14, 2024 | $4.07 |
| Nov 15, 2024 | $3.83 |
| Nov 18, 2024 | $3.78 |
| 4 days before | 65.00% |
| 4 days after | -18.18% |
| On release day | -10.61% |
| Change in period | 35.00% |
Q4 2024
Beat
| Release date | Mar 13, 2025 |
| Fiscal end date | Dec 31, 2024 |
| Price on release | $1.59 |
| EPS estimate | -$0.460 |
| EPS actual | -$0.355 |
| EPS surprise | 22.80% |
| Date | Price |
|---|---|
| Mar 07, 2025 | $1.74 |
| Mar 10, 2025 | $1.68 |
| Mar 11, 2025 | $1.68 |
| Mar 12, 2025 | $1.77 |
| Mar 13, 2025 | $1.59 |
| Mar 14, 2025 | $1.68 |
| 4 days before | -8.62% |
| 4 days after | 5.66% |
| On release day | 5.66% |
| Change in period | -3.45% |
Aemetis Earnings Call Transcript Summary of Q4 2024
Financial Overview
Cost of Goods Sold (COGS): COGS increased to $268.2 million in 2024, matching revenue growth and resulting in a gross loss of $580,000, compared to a gross profit of $2 million in 2023.
Operating Loss: Operating loss for the year was $40.4 million, which is consistent with the previous year.
Net Loss: The net loss was $87.5 million, worsening from a loss of $46.4 million in 2023.
Cash Position: Cash reserves decreased to $898,000 by the end of 2024, from $2.7 million a year earlier.
Capital Expenditures: Investments of $20.3 million were made towards carbon intensity reduction and biogas production capacity expansion.
Business Developments
- Biogas Expansion: Aemetis aims to grow its biogas production capacity, targeting 550,000 MMBtu per year in 2025 and 1 million MMBtu in 2026, supported by loans from the USDA.
- SAF and RD Plant: Aemetis received construction permits for a sustainable aviation fuel and renewable diesel plant, aiming for a 90 million gallon annual capacity.
- India Biodiesel: The India segment faces delays in biodiesel deliveries, impacting operations temporarily. An IPO is anticipated in late 2025 or early 2026.
Market and Policy Environment
- Low Carbon Fuel Standard (LCFS): Recent LCFS amendments are expected to increase the value of Aemetis’ products significantly and support new investment. However, there's a delay in the implementation process that has caused a temporary drop in credit prices.
- Federal Incentives: Key federal policies such as the renewable fuel standard (RFS) and production tax credits (in effect from January 2025) are crucial for Aemetis' growth prospects. A clear pathway for these credits is still pending.
- Ethanol Market: An expected approval of E15 ethanol blends will potentially increase the U.S. ethanol market by 50%, improving margins for Aemetis.
CEO Insights
- Confidence remains high in securing further USDA loans for ongoing projects despite recent regulatory turbulence.
- The company emphasizes a "circular bioeconomy" approach across its segments aimed at maximizing efficiency and profitability.
Investor Considerations
- Monitoring the regulatory developments surrounding LCFS and E15 approvals will be crucial for Aemetis’ growth prospects.
- Potential upside from expanding markets for renewable fuels, particularly if federal support strengthens.
- Challenges persist with high operating losses and the need for successful execution of expansion plans.
Aemetis Earnings History
Earnings Calendar
FAQ
When is the earnings report for AMTX?
Aemetis (AMTX) has scheduled its earnings report for May 07, 2025 before the markets open.
What is the AMTX price-to-earnings (P/E) ratio?
AMTX P/E ratio as of Mar 14, 2025 (TTM) is -0.88.
What is the AMTX EPS forecast?
The forecasted EPS (Earnings Per Share) for Aemetis (AMTX) for the first fiscal quarter 2025 is -$0.307.
What are Aemetis's retained earnings?
On its balance sheet, Aemetis reported retained earnings of $47.00 million for the latest quarter ending Dec 31, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
